Potentiation Of Anticancer Antibody Efficacy By Antineoplastic Drugs: Detection Of Antibody-Drug Synergism Using The Combination Index Equation

JOVE-JOURNAL OF VISUALIZED EXPERIMENTS(2019)

引用 4|浏览4
暂无评分
摘要
Potentiation of hostile monoclonal antibodies (mAb) by chemotherapeutic agents constitutes a valuable strategy for designing effective and safer therapy against cancer. Here we provide a protocol to identify a rational combination at the preclinical step. First, we describe a cell-based assay to assess the synergism between anticancer mAb and cytotoxic drugs, that uses the combination index equation of Chou and Talalay(1). This includes the measurement of tumor cell drug- and antibody-sensitivity using an MTT assay, followed by an automated computer analysis to calculate the combination index (CI) values. CI values of <1 indicate synergism between tested mAbs and cytotoxic agents(1). To corroborate the in vitro findings in vivo, we further describe a method to assess the combination regimen efficacy in a xenograft tumor model. In this model, the combined regimen significantly delays tumor growth, which results in a significant extended survival in comparison to single-agent controls. Importantly, the in vivo experimentation reveals that the combination regimen is well tolerated. This protocol allows the effective evaluation of anticancer drug combinations in preclinical models and the identification of rational combination to evaluate in clinical trials.
更多
查看译文
关键词
Cancer Research,Issue 143,Cancer research,drug development,antibody-drug combination,antibody-drug interaction,MTT assay,antibody-drug synergy,combination index equation,in vitro cell line model,tumor xenograft model
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要